MiMedx Group, Inc. Operating Leases, Income Statement, Sublease Revenue
MiMedx Group, Inc. (MDXG) reported Operating Leases, Income Statement, Sublease Revenue of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-08.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue · last filed 2021-03-08
- MiMedx Group, Inc. operating leases, income statement, sublease revenue for fiscal 2018 was $0.00.
| Period end | Operating Leases, Income Statement, Sublease Revenue 12 month |
|---|---|
| 2018-12-31 | $0.00 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |